[{"AccountsPayableCurrent_0_FY_USD":1174000.0,"ConstructionInProgressExpendituresIncurredButNotYetPaid_4_FY_USD":25000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_4_FY_USD":1294000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_FY_USD":3000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_FY_USD":26000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":53128000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":4551000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_4_FY_USD":1140000.0,"MarketableSecuritiesCurrent_0_FY_USD":53151000.0,"ProceedsFromSaleOfProductiveAssets_4_FY_USD":20000.0,"OtherLiabilitiesNoncurrent_0_FY_USD":15551000.0,"OtherAssetImpairmentCharges_4_FY_USD":1800000.0,"DefinedContributionPlanEmployerMatchingContributionPercent_4_FY_pure":0.04,"IncreaseDecreaseInAccountsAndOtherReceivables_4_FY_USD":-2274000.0,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":4575000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":4551000.0,"IntangibleAssetsNetExcludingGoodwill_0_FY_USD":48690000.0,"OtherLiabilitiesCurrent_0_FY_USD":2026000.0,"IncreaseDecreaseInOtherOperatingAssets_4_FY_USD":39000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_FY_USD":2600000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_4_FY_USD":113173000.0,"AccountsAndOtherReceivablesNetCurrent_0_FY_USD":1015000.0,"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_4_FY_USD":-2170000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4_FY_USD":36000.0,"GainLossOnSaleOfPropertyPlantEquipment_4_FY_USD":-11000.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_4_FY_USD":-13869000.0,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_4_FY_pure":0.5,"OtherLiabilities_0_FY_USD":17577000.0,"StockIssuedDuringPeriodValueOther_4_FY_USD":16248000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_FY_USD":-10447000.0,"ContractWithCustomerAssetNet_0_FY_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":-50878000.0,"ContractWithCustomerLiability_0_FY_USD":254000.0,"DeferredTaxAssetsPropertyPlantAndEquipment_0_FY_USD":1759000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_FY_USD":887000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":3573000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_4_FY_USD":0.0,"ProceedsFromStockPlans_4_FY_USD":9000.0,"PaymentsToAcquireMarketableSecurities_4_FY_USD":95382000.0,"OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_0_FY_USD":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.11,"OperatingLeaseRightOfUseAsset_0_FY_USD":3473000.0,"OperatingLeasePayments_4_FY_USD":3300000.0,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":1713000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":1944000.0,"OperatingLeaseLiability_0_FY_USD":3657000.0,"OperatingLeaseCost_4_FY_USD":2500000.0,"NumberOfOperatingSegments_4_FY_segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":494000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":875000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_FY_USD":747000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_FY_USD":311000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":4151000.0,"InvestmentsAndCash_0_FY_USD":64400000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_FY_USD":48700000.0,"IncomeTaxReconciliationTaxCreditsResearch_4_FY_USD":1902000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4_FY_USD":0.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_4_FY_pure":0.6,"DefinedContributionPlanCostRecognized_4_FY_USD":300000.0,"DeferredTaxAssetsTaxDeferredExpenseOther_0_FY_USD":328000.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":12651000.0,"DeferredTaxAssetsTaxDeferredExpense_0_FY_USD":70042000.0,"DeferredTaxAssetsTaxCreditCarryforwards_0_FY_USD":42642000.0,"ContractWithCustomerLiabilityRevenueRecognized_4_FY_USD":1400000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4_FY_USD":9000.0,"DepreciationDepletionAndAmortization_4_FY_USD":4858000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-50842000.0,"AccruedLiabilitiesCurrent_0_FY_USD":6499000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":14507000.0,"StockholdersEquity_0_FY_USD":94026000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-1013316000.0,"PropertyPlantAndEquipmentNet_0_FY_USD":4031000.0,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":16248000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":1300000.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":731000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-46415000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":17080000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":16257000.0,"LiabilitiesCurrent_0_FY_USD":11643000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":122933000.0,"Liabilities_0_FY_USD":28907000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":-362000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4_FY_USD":-50878000.0,"GeneralAndAdministrativeExpense_4_FY_USD":15426000.0,"EarningsPerShareBasicAndDiluted_1_FY_USD":-0.64,"EarningsPerShareBasicAndDiluted_4_FY_USD":-3.51,"CostsAndExpenses_4_FY_USD":58604000.0,"CommonStockValue_0_FY_USD":17000.0,"CommonStockSharesOutstanding_0_FY_shares":16972077.0,"CommonStockSharesIssued_0_FY_shares":16972077.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_4_FY_USD":-13078000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":11232000.0,"AssetsCurrent_0_FY_USD":66698000.0,"Assets_0_FY_USD":122933000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":1700312.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":2619000.0,"CommitmentsAndContingencies_0_FY_USD":null,"ValuationAllowanceDeferredTaxAssetChangeInAmount_4_FY_USD":2927000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.001,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"AdditionalPaidInCapitalCommonStock_0_FY_USD":1104706000.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":338000.0,"OtherAssetsNoncurrent_0_FY_USD":41000.0,"IncomeTaxReconciliationOtherAdjustments_4_FY_USD":-1011000.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4_FY_USD":-10684000.0,"DeferredTaxLiabilities_0_FY_USD":3007000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":290426000.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":172745000.0,"DeferredTaxAssetsGross_0_FY_USD":300167000.0,"CostOfGoodsAndServicesSold_4_FY_USD":100000.0,"BusinessCombinationContingentConsiderationLiability_0_FY_USD":12485000.0,"InterestReceivable_0_FY_USD":200000.0,"AccruedProfessionalFeesCurrent_0_FY_USD":400000.0,"PropertyPlantAndEquipmentGross_0_FY_USD":32434000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":2218000.0,"InterestAndOtherIncome_4_FY_USD":4153000.0,"IncreaseDecreaseInOtherOperatingLiabilities_4_FY_USD":-6599000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4_FY_USD":-321000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":28403000.0,"ShareBasedCompensation_4_FY_USD":4551000.0,"ResearchAndDevelopmentExpense_4_FY_USD":42672000.0,"PreferredStockValue_0_FY_USD":null,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"PreferredStockSharesAuthorized_0_FY_shares":3000000.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.01,"OperatingIncomeLoss_4_FY_USD":-55031000.0,"IncomeTaxReconciliationStateAndLocalIncomeTaxes_4_FY_USD":-2170000.0,"IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_USD":-2927000.0,"CommonStockSharesAuthorized_0_FY_shares":297000000.0,"VariableLeaseCost_4_FY_USD":1500000.0,"Ticker":"CLDX","CIK":"744218","name":"CELLDEX THERAPEUTICS, INC.","OfficialName":"Celldex Therapeutics Inc.","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1601609341.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20200326"}]